Bifalgorithm post · 10 Cancer Treatment Approvals From September 2026 and What They Mean for You · 3. A Shorter Hospital Stay for Imdelltra
Monitoring Update
Monitoring Update (10 Cancer Treatment Approvals From September 2026 and What They Mean for You · 3. A Shorter Hospital Stay for Imdelltra) — "People starting…
Ideas in this flowchart
- Updated safety requirements for people starting Imdelltra
- Imdelltra (tarlatamab) is used for extensive-stage small cell lung cancer.
- The first two doses now require 6 to 8 hours of monitoring after each dose.
- The monitoring period is reduced from 22 to 24 hours.
- Additional precautions remain necessary after each of the first two doses.
- Patients must stay within an hour of a medical facility.
- Patients must have a caregiver.
- These precautions apply for 48 hours after each dose.
